Immunoaffinity-Based Liquid Chromatography Mass Spectrometric Assay to Accurately Quantify the Protein Concentration of HMGB1 in EDTA Plasma

Anselm, Viktoria; Steinhilber, Andreas; Sommersdorf, Cornelia; Poetz, Oliver

doi:10.1007/978-1-0716-1186-9_17

Cited by 1 publication

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two successful reports on the measurement of HMGB1 in human samples applied nano-LC-MS/MS to achieve adequate detection. They found plasma concentrations in healthy subjects to be less than 1 ng/mL [17,19]. Hence, more work is needed to improve the LOD, perhaps facilitated by new and improved MS detection.…”

Section: Future Perspectives 231 Methods Improvementmentioning

confidence: 99%

“…LC-MS/MS provides multiple dimensions for the selective detection of HMGB1, including retention time, as well as molecular ion and fragment ion masses (m/z) as identification parameters. Recent advancements in LC-MS/MS methods for HMGB1 have implemented immunoaffinity extraction (IAE) to isolate either intact HMGB1 [16][17][18] or peptides derived from HMGB1 after enzymatic cleavage [19]. The former approach suffers from interference by various binding proteins, such as autoantibodies, whereas the latter approach only catches part of the protein and does not allow for the full study of post-translational modifications (PTMs) [20].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein

et al. 2021

View full text Add to dashboard Cite

Sickness behavior and fatigue are induced by cerebral mechanisms involving inflammatory cytokines. High mobility group box 1 (HMGB1) is an alarmin, and a potential key player in this process. Reliable quantification methods for total HMGB1 and its redox variants must be established in order to clearly understand how it functions. Current methods pose significant challenges due to interference from other plasma proteins and autoantibodies. We aimed to develop an antibody-free sample preparation method followed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to measure HMGB1 in human plasma. Different methods were applied for the removal of interfering proteins and the enrichment of HMGB1 from spiked human plasma samples. A comparison of methods showed an overall low extraction recovery (<40%), probably due to the stickiness of HMGB1. Reversed-phase liquid chromatography separation of intact proteins in diluted plasma yielded the most promising results. The method produced an even higher degree of HMGB1 purification than that observed with immunoaffinity extraction. Detection sensitivity needs to be further improved for the measurement of HMGB1 in patient samples. Nevertheless, it has been demonstrated that a versatile and fully antibody-free sample preparation method is possible, which could be of great use in further investigations.

show abstract

Section: Future Perspectives 231 Methods Improvementmentioning

confidence: 99%